Delivery Order SPE2DB20D2014-SPE2DB25FD10H
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a ceiling value of $2,578.26. This is a firm fixed-price delivery order issued under a non-competitive set-aside arrangement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $31,540.49 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,524.09 delivery order on July 29, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count). This is a firm fixed-price, competitively awarded contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 30, 2025. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $11,522.91 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on September 12, 2025, with completion scheduled for September 15, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $6,132.01 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This firm fixed price, competitively awarded contract represents a non-set-aside procurement and is scheduled for completion by September 29, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $16,902.11 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) with a ceiling value of $4,180.59 under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by September 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a $2,041.98 delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed price, non-set-aside contract with a completion date of June 13, 2025, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $20,357.51 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $32,533.93 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). The contract, which is not set-aside, is set to conclude by September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD10HDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on September 24, 2025, with a ceiling value of $26,026.55. This is a firm fixed-price delivery order with no set-aside designation, executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company holds a $999.99 billion IDC with DLA Troop Support Medical (designated SPE2DX) through December 2026, which provides a comprehensive vehicle for supplying pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains to support global military healthcare programs. This delivery order for Trelegy Ellipta—a respiratory medication used to treat chronic obstructive pulmonary disease—represents one of numerous competitively awarded orders fulfilled through this prime contract vehicle to serve the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.0k | 9/24/25 |